LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.31623
 51.33 27.76 975 5117 0.1905 0.6046
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 51.33 27.76 1036 5117 0.2025 0.6176
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 51.33 27.76 1046 5117 0.2044 0.6196
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 53.04 27.76 966 5365 0.1800 0.5958
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 53.04 27.76 977 5365 0.1821 0.5982
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 53.04 27.76 1106 5365 0.2061 0.6245
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 53.04 27.76 1130 5365 0.2106 0.6291
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 54.74 27.76 983 5606 0.1753 0.5933
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 54.74 27.76 996 5606 0.1777 0.5960
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 54.74 27.76 1071 5606 0.1910 0.6112
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 54.74 27.76 1086 5606 0.1937 0.6141
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 56.45 27.76 999 5745 0.1739 0.5932
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 56.45 27.76 1013 5745 0.1763 0.5961
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 56.45 27.76 1084 5745 0.1887 0.6102
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 56.45 27.76 1099 5745 0.1913 0.6131
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 58.15 27.76 1000 5906 0.1693 0.5896
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 58.15 27.76 1010 5906 0.1710 0.5916
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 58.15 27.76 1099 5906 0.1861 0.6091
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 58.15 27.76 1114 5906 0.1886 0.6119
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 59.85 27.76 991 6062 0.1635 0.5842
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 59.85 27.76 1006 6062 0.1659 0.5873
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 59.85 27.76 1095 6062 0.1806 0.6047
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 59.85 27.76 1116 6062 0.1841 0.6086
MN20160318_Q01
H10
MCF 10A-H2B-mCherry Trametinib
0.31623
 61.56 27.76 974 6217 0.1567 0.5773
MN20160318_Q01
D06
MCF 10A-H2B-mCherry Trametinib
0.31623
 61.56 27.76 994 6217 0.1599 0.5814
MN20160318_Q01
D06